Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael Stolten"'
Publikováno v:
Journal of Radiotherapy in Practice. 18:397-399
Background:Use of molecular information to guide clinical management of thoracic liposarcoma following resection.Case presentation:We present a case of a large liposarcoma of the left hemithorax. Initial biopsy consistent with lipoma however followin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::474bcd9f21489e8e6c243dd80c57e8b9
https://doi.org/10.1017/s1460396919000372
https://doi.org/10.1017/s1460396919000372
Publikováno v:
Clinical Genitourinary Cancer. 14:149-152
Background The ratio of the second to the fourth digits (2D:4D) has been linked to prenatal androgen exposure and prostate cancer (PCa). The use of alternative finger ratios has been shown to be a greater indicator of sexual dimorphism when compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5103a1b737773d29856b91f05ff3a73
https://doi.org/10.1016/j.clgc.2015.11.005
https://doi.org/10.1016/j.clgc.2015.11.005
Autor:
Allie E. Steinberger, Eric Luk, Oliver Sartor, Jonathan L. Silberstein, Michael Stolten, Daniel Desmond, Patrick Cotogno, Allison H. Feibus, Elisa Ledet
Publikováno v:
Clinical Genitourinary Cancer. 14:139-148
Careful descriptions of men with prostate cancer (PCa)-specific mortality are scant in nontrial settings. The present retrospective review describes the clinical characteristics, timelines, and treatment histories from initial presentation to death i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0b17597a6a5fe056328ccd4e659a7b
https://doi.org/10.1016/j.clgc.2015.11.003
https://doi.org/10.1016/j.clgc.2015.11.003
Autor:
Christopher Jackson, Stephanie A. Terezakis, S. Segal, Bradford S. Hoppe, E. Song, Richard W. Tsang, Chris R. Kelsey, Chelsea C. Pinnix, Carla Casulo, Sarah A. Milgrom, N. G. Mikhaeel, Andrew Wirth, Umberto Ricardi, Hans-Theodor Eich, Richard T. Hoppe, I. Maghfoor, Mario Levis, Andrea K. Ng, M S Rauf, Youlia M. Kirova, Kenneth B. Roberts, R. Advani, Louis S. Constine, S. Akhtar, Michael S. Binkley, Jessica L. Brady, Julie L. Koenig, Sarah Gao, Michael Stolten, Yaso Natkunam
Publikováno v:
Hematological Oncology. 37:145-146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6d481dd06e5b8eb55553dc58afffb79
https://doi.org/10.1002/hon.103_2629
https://doi.org/10.1002/hon.103_2629
Publikováno v:
Clinical Pediatrics. 55:196-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7395db8b7e409b1d964da987b2812e2
https://doi.org/10.1177/0009922815599939
https://doi.org/10.1177/0009922815599939
Publikováno v:
Clinical Pediatrics. 55:199-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee342917c0efac2e635f36817bd80be1
https://doi.org/10.1177/0009922815595063
https://doi.org/10.1177/0009922815595063
Autor:
Allison H. Feibus, Elisa M. Ledet, Michael Stolten, A. Oliver Sartor, Brian E. Lewis, Aryeneesh Dotiwala, Allie E. Steinberger, Vikram J. Premkumar
Publikováno v:
Journal of Clinical Oncology. 34:339-339
339 Background: The current treatment paradigm for metastatic, castrate-resistant prostate cancer (mCRPC) has rapidly changed and six therapies [abiraterone (Abi), enzalutamide (Enza), docetaxel (Doc), cabazitaxel (Cab), radium-223 (Ra-223), and sipu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c767544dbafd80f0bb0e3b4243607c1
https://doi.org/10.1200/jco.2016.34.2_suppl.339
https://doi.org/10.1200/jco.2016.34.2_suppl.339
Autor:
A. Oliver Sartor, Allie E. Steinberger, Patrick Cotogno, Jeffrey R. Guccione, Brian E. Lewis, Elisa M. Ledet, Michael Stolten, Lydia D. Chow
Publikováno v:
Journal of Clinical Oncology. 34:249-249
249 Background: Abi and Enza are used in treating metastatic CRPC. Primary resistance is well described but little data exists for early treatment responders. Further characterization of patients with early PSA declines was the goal of this study. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59cb42309d9afa5d475bb6d0db2bd6d
https://doi.org/10.1200/jco.2016.34.2_suppl.249
https://doi.org/10.1200/jco.2016.34.2_suppl.249
Autor:
Patrick Cotogno, Allie E. Steinberger, Oliver Sartor, Brian E. Lewis, Michael Stolten, Elisa Ledet
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:E196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ffc8d84e0547bef7353643131258272
https://doi.org/10.1016/j.ijrobp.2015.07.1047
https://doi.org/10.1016/j.ijrobp.2015.07.1047
Autor:
Michael Stolten, Oliver Sartor, Allie E. Steinberger, Jonathan L. Silberstein, Daniel Desmond, Patrick Cotogno, Elisa M. Ledet, Eric Luk
Publikováno v:
Journal of Clinical Oncology. 33:239-239
239 Background: Careful study of treatments in men with prostate cancer (PCa)-specific mortality is scant in non-trial settings. We sought to examine the characteristics and use of selected therapies in men dying from PCa, beginning from the time of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e4addda313a0b2330b1bc6705806bf
https://doi.org/10.1200/jco.2015.33.7_suppl.239
https://doi.org/10.1200/jco.2015.33.7_suppl.239